IE
AMBI

Israel Englander’s Ambit Biosciences Corp AMBI Stock Holding History

Israel Englander’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-100,810
Closed -$1.56M – 4069
2013
Q3 		$1.56M Buy
+100,810
New +$1.34M 0.01% 1838

Other funds holding AMBI

FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Israel Englander's AMBI Position: Q4 2013 in Review

Israel Englander sold out of Ambit Biosciences Corp (AMBI) in Q4 2013, closing a stake of 100,810 shares — an estimated $1.56M sold.

Israel Englander first reported a position in AMBI in Q3 2013 and held it in 1 quarter. The position peaked at $1.56M in Q3 2013. 35 funds tracked by Wall St. Rank hold AMBI as of Q4 2013.

  • Israel Englander reported no remaining Ambit Biosciences Corp position as of Q4 2013 after selling out during the quarter.
  • Israel Englander sold 100,810 Ambit Biosciences Corp shares in Q4 2013, an estimated $1.56M.
  • Israel Englander first reported a position in Ambit Biosciences Corp in Q3 2013 and held it in 1 quarter.
  • Israel Englander's Ambit Biosciences Corp position peaked at $1.56M in Q3 2013.
  • 35 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2013.

Based on Millennium Management's 13F filing for Q4 2013, filed 14 Feb 2014.